Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01014546
Previous Study | Return to List | Next Study

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

This study has been terminated.
(low accrual)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: November 16, 2009
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)